Bragar Eagel & Squire, P.C. is investigating potential federal securities-law violations and other unlawful business practices involving Alignment Healthcare, Inc. (NASDAQ: ALHC). The investigation follows a July 8, 2026, Modern Healthcare report about a former executive’s whistleblower lawsuit alleging that Alignment classified routine software maintenance and production-support costs as capital expenditures. The alleged accounting treatment inflated adjusted EBITDA and enabled Alignment to report its first full year of positive adjusted EBITDA as a public company, according to the lawsuit. Alignment shares fell $4.02, or 16.7%, to close at $20.03 on July 8. Kaplan Fox & Kilsheimer LLP also previously announced an investigation into the allegations. Investors who acquired Alignment shares, suffered losses or have relevant information may contact either firm; Bragar Eagel & Squire says there is no cost or obligation to do so.